Search Results - "Casacó, Angel"
-
1
Radiosensitization induced by the anti-epidermal growth factor receptor monoclonal antibodies cetuximab and nimotuzumab in A431 cells
Published in Cancer biology & therapy (15-01-2012)“…Epidermal growth factor receptors (EGFR) are overexpressed in a wide range of malignancies including head and neck, colon, and breast cancers. It has been…”
Get full text
Journal Article -
2
Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study Trial
Published in Frontiers in pharmacology (10-05-2017)“…Metastatic castration-resistant prostate cancer (CRPC) remains incurable due to the lack of effective therapies. Activation of the human epidermal growth…”
Get full text
Journal Article -
3
Considerations for reducing the euthanasia procedure in toxicological studies of biopharmaceuticals using non-human primates
Published in Toxicology (Amsterdam) (01-10-2009)Get full text
Journal Article -
4
Expression and biological characterization of an anti-CD20 biosimilar candidate antibody: A case study
Published in mAbs (01-07-2012)“…The CD20 molecule is a non-glycosylated protein expressed mainly on the surface of B lymphocytes. In some pathogenic B cells, it shows an increased expression,…”
Get full text
Journal Article -
5
Effects of an epidermal growth factor receptor-based cancer vaccine on wound healing and inflammation processes in murine experimental models
Published in International wound journal (01-02-2014)“…Anti‐epidermal growth factor receptor (EGFR) therapies have been proven clinically effective for a variety of epithelial tumours. Vaccination of mice with the…”
Get full text
Journal Article -
6
Effect of blockade of the EGF system on wound healing in patients vaccinated with CIMAvax® EGF
Published in World journal of surgical oncology (15-10-2013)“…The epidermal growth factor receptor (EGFR) signaling system is frequently unbalanced in human malignancies due to increased ligand production, receptor…”
Get full text
Journal Article -
7
Evaluation of nimotuzumab Fab2 as an optical imaging agent in EGFR positive cancers
Published in Scientific reports (07-07-2023)“…Molecular-targeted imaging probes can be used with a variety of imaging modalities to detect diseased tissues and guide their removal. EGFR is a useful…”
Get full text
Journal Article -
8
Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety
Published in BMC cancer (12-03-2021)“…Epidermal growth factor receptor (EGFR) is a target for cancer therapy as it is overexpressed in a wide variety of cancers. Therapeutic antibodies that bind…”
Get full text
Journal Article -
9
Pharmacokinetic comparison of two recombinant human granulocyte colony-stimulating factor after subcutaneous administration in rabbits
Published in European journal of pharmaceutics and biopharmaceutics (01-10-2005)“…A pharmacokinetic comparison between two formulations (LeukoCIM, CIMAB SA versus Neupogen ®, Hoffman-La Roche, licensed by Amgen) of recombinant human…”
Get full text
Journal Article -
10
Immunohistochemical recognition of the epidermal growth factor receptor by the h-R3 antibody in the skin of experimental animals
Published in Applied immunohistochemistry & molecular morphology (01-12-2004)“…The h-R3 is a humanized monoclonal antibody (Mab) that binds to the external domain of the human epidermal growth factor receptor (EGF-R). It has being used…”
Get full text
Journal Article -
11
Non-clinical immuno-toxicological evaluation of HER1 cancer vaccine in non-human primates: a 12-month study
Published in Vaccine (17-12-2012)“…Highlights ► We assessed the immunotoxicity of HER1 vaccine in Macaca fascicularis . ► Treated monkeys received 9 doses of vaccination in a 12 months period. ►…”
Get full text
Journal Article -
12
Systemic and skin toxicity in cercopithecus aethiops sabaeus monkeys treated during 26 weeks with a high intravenous dose of the anti-epidermal growth factor receptor monoclonal antibody nimotuzumab
Published in Cancer biology & therapy (01-09-2007)“…Nimotuzumab (h-R3) is a humanized anti-epidermal growth factor receptor monoclonal antibody (mAb) registered for treating head and neck tumours. The present…”
Get full text
Journal Article -
13
Local and systemic toxicity of h-R3, an anti-epidermal growth factor receptor monoclonal antibody, labeled with 188osmiun after the intracerebral administration in rats
Published in Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie (01-03-2005)“…h-R3 is a humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody (MAb). This receptor is over-expressed in the majority of tumors of…”
Get full text
Journal Article -
14
Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188-Re in adult recurrent high-grade glioma
Published in Cancer biology & therapy (01-03-2008)“…Radioimmunotherapy (RIT) may improve the management of malignant gliomas. A Phase I clinical trial was performed to evaluate, for the first time, the toxicity…”
Get full text
Journal Article -
15
Hematological, biochemical, respiratory, cardiovascular and electroneurophysiological parameters in African green monkeys (Cercopithecus aethiops sabaeus). Its use in non-clinical toxicological studies
Published in Journal of medical primatology (01-06-2010)“…Background The purpose of this study is to better characterize the hematological, biochemical, respiratory, cardiovascular and electroneurophysiological…”
Get full text
Journal Article -
16
Immuno-toxicological evaluation of her1 cancer vaccine in non-human primates: a 6-month subcutaneous study
Published in Immunopharmacology and immunotoxicology (04-05-2021)“…Purpose: A vaccine composition based on the extracellular domain of the human epidermal growth factor receptor 1 (HER1-ECD) and the combination of VSSP (very…”
Get full text
Journal Article -
17
Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)Tc
Published in Breast cancer research and treatment (01-03-2006)“…The relevance of certain gangliosides in tumour growth and metastatic dissemination has been well documented, reasons for considering these molecules as…”
Get full text
Journal Article -
18
The chicken animal model for ovarian cancer and for pharmacological and toxicological evaluation of NGcGM3 ganglioside based treatments
Published in Toxicology letters (20-10-2017)Get full text
Journal Article -
19
Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with 99mTc
Published in Breast cancer research and treatment (01-03-2006)“…The relevance of certain gangliosides in tumour growth and metastatic dissemination has been well documented, reasons for considering these molecules as…”
Get full text
Journal Article -
20
Preclinical studies predicting low clinical toxicity of the anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) nimotuzumab
Published in Toxicology letters (05-10-2008)Get full text
Journal Article